<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">

<head>
<meta content="en-us" http-equiv="Content-Language" />
<meta content="text/html; charset=utf-8" http-equiv="Content-Type" />
<title>Kiran Mazumdar-Shaw</title>
<style type="text/css">
.auto-style1 {
	color: rgb(0, 0, 0);
}
</style>
</head>

<body>

<h1 id="firstHeading" class="firstHeading" lang="en" style="color: rgb(0, 0, 0); background: none; font-weight: normal; margin: 0px 0px 0.25em; overflow: visible; padding: 0px; border-bottom: 1px solid rgb(170, 170, 170); font-size: 1.8em; line-height: 1.3; font-family: &quot;Linux Libertine&quot;, Georgia, Times, serif; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px;">
Kiran Mazumdar-Shaw:</h1>
<p>
<img alt="Kiran Mazumdar-Shaw HD2014 crop.jpg" src="twentypos14image.jpg" width="100%" /></p>
<h2 style="color: rgb(0, 0, 0); background: none rgb(255, 255, 255); font-weight: normal; margin: 1em 0px 0.25em; overflow: hidden; padding: 0px; border-bottom: 1px solid rgb(170, 170, 170); font-size: 1.5em; font-family: &quot;Linux Libertine&quot;, Georgia, Times, serif; line-height: 1.3; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px;">
<span id="Early_life_and_education" class="mw-headline">Early life and education</span></h2>
<p style="margin: 0.5em 0px; line-height: inherit; color: rgb(37, 37, 37); font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
<span class="auto-style1">Kiran Mazumdar was born to Gujarati parents in<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Bangalore" style="text-decoration: none; background: none;" title="Bangalore">Bangalore</a><span class="auto-style1">, 
India.She went to school at Bangalore’s<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Bishop_Cotton_Girls'_School" style="text-decoration: none; background: none;" title="Bishop Cotton Girls' School">Bishop 
Cotton Girl's High School</a><span class="auto-style1">, graduating in 1968. She 
then attended<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Mount_Carmel_College,_Bangalore" style="text-decoration: none; background: none;" title="Mount Carmel College, Bangalore">Mount 
Carmel College, Bangalore</a><span class="auto-style1">, a women's college 
offering pre-university courses as an affiliate of Bangalore University. She 
studied biology and zoology, graduating from<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Bangalore_University" style="text-decoration: none; background: none;" title="Bangalore University">Bangalore 
University</a><span class="auto-style1">&nbsp;with a B.Sc. in Zoology in 
1973.Mazumdar hoped to go to medical school, but did not obtain a scholarship.</span></p>
<p style="margin: 0.5em 0px; line-height: inherit; color: rgb(37, 37, 37); font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
<span class="auto-style1">Her father, Rasendra Mazumdar, was the head brewmaster 
at<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/United_Breweries_Group" style="text-decoration: none; background: none;" title="United Breweries Group">United 
Breweries</a><span class="auto-style1">. He suggested that Kiran study<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Fermentation" style="text-decoration: none; background: none;" title="Fermentation">fermentation</a><span class="auto-style1">&nbsp;science, 
and train to be a brewmaster, a very nontraditional field for a woman.Mazumdar 
went to<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Federation_University" style="text-decoration: none; background: none;" title="Federation University">Federation 
University</a><span class="auto-style1">&nbsp;(Formerly known as University of 
Ballarat) in Australia to study Malting and Brewing. In 1974 she was the only 
woman enrolled in the brewing course, and the top of her class.<span class="Apple-converted-space">&nbsp;</span>She 
earned the degree of Master Brewer in 1975.</span></p>
<p class="auto-style1" style="margin: 0.5em 0px; line-height: inherit; font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
She worked as a trainee brewer in Carlton and United Breweries, Melbourne and as 
a trainee maltster at Barrett Brothers and Burston, Australia. She also worked 
for some time as a technical consultant at Jupiter Breweries Limited, Calcutta 
and as a technical manager at Standard Maltings Corporation, Baroda between 1975 
and 1977.<span class="Apple-converted-space">&nbsp;</span>However, when she 
investigated the possibility of further work in Bangalore or Delhi, she was told 
that she would not be hired as a master brewer in India because "It's a man's 
work.<span class="Apple-converted-space">&nbsp;</span>She began to look abroad, and 
was offered a position in Scotland.</p>
<p style="margin: 0.5em 0px; line-height: inherit; color: rgb(37, 37, 37); font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
<span class="auto-style1">Before Kiran could move, she met<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/w/index.php?title=Leslie_Auchincloss&amp;action=edit&amp;redlink=1" style="text-decoration: none; background: none;" title="Leslie Auchincloss (page does not exist)">Leslie 
Auchincloss</a><span class="auto-style1">, founder of Biocon Biochemicals 
Limited, of Cork, Ireland. Auchincloss's company produced enzymes for use in the 
brewing, food-packaging and textile industries. Auchincloss was looking for an 
Indian entrepreneur to help establish an Indian subsidiary.<span class="Apple-converted-space">&nbsp;</span>Mazumdar 
agreed to undertake the job on the condition that if she did not wish to 
continue after six months she would be guaranteed a brewmaster's position 
comparable to the one she was giving up.</span></p>
<h3 class="auto-style1" style="background: none rgb(255, 255, 255); font-weight: bold; margin: 0.3em 0px 0px; overflow: hidden; padding-top: 0.5em; padding-bottom: 0px; font-size: 1.2em; line-height: 1.6; font-family: sans-serif; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; border-bottom-style: none; border-bottom-color: inherit; border-bottom-width: medium;">
<span id="Beginning_with_enzymes" class="mw-headline">Beginning with enzymes</span></h3>
<p class="auto-style1" style="margin: 0.5em 0px; line-height: inherit; font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
After a brief period as a Trainee Manager at Biocon Biochemicals Limited, of 
Cork, Ireland, to learn more about the business, Kiran Mazumdar Shaw returned to 
India.<span class="Apple-converted-space">&nbsp;</span>She started Biocon India in 
1978 in the garage of her rented house in Bengaluru with a seed capital of Rs. 
10,000.<span class="Apple-converted-space">&nbsp;</span>Although it was a joint 
venture, Indian laws restricted foreign ownership to 30% of the company. The 
remaining 70% belonged to Kiran Mazumdar Shaw.</p>
<p style="margin: 0.5em 0px; line-height: inherit; color: rgb(37, 37, 37); font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
<span class="auto-style1">Initially, she faced credibility challenges because of 
her youth, gender and her untested business model. Funding was a problem: no 
bank wanted to lend to her, and some requested that her father be a guarantor. A 
chance meeting with a banker at a social event finally enabled her to get her 
first financial backing.<span class="Apple-converted-space">&nbsp;</span>She also 
found it difficult to recruit people to work for her start-up. Her first 
employee was a retired garage mechanic.<span class="Apple-converted-space">&nbsp;</span>Her 
first factory was in a nearby 3,000-square-foot shed.<span class="Apple-converted-space">&nbsp;</span>The 
most complicated piece of equipment in her lab at that time was a<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Spectrophotometer" style="text-decoration: none; background: none;" title="Spectrophotometer">spectrophotometer</a><span class="auto-style1">.As 
well, she faced the technological challenges associated with trying to build a 
biotech business in a country with a shaky infrastructure.Uninterrupted power, 
superior quality water, sterile labs, imported research equipment, and workers 
with advanced scientific skills were not easily available in India at the time.</span></p>
<p style="margin: 0.5em 0px; line-height: inherit; color: rgb(37, 37, 37); font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
<span class="auto-style1">The company's initial projects were the extraction of<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Papain" style="text-decoration: none; background: none;" title="Papain">papain</a><span class="auto-style1">&nbsp;(an 
enzyme from papaya used to tenderize meat) and<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Isinglass" style="text-decoration: none; background: none;" title="Isinglass">isinglass</a><span class="auto-style1">&nbsp;(obtained 
from tropical catfish and used to clarify beer).<span class="Apple-converted-space">&nbsp;</span>Within 
a year of its inception, Biocon India was able to manufacture enzymes and to 
export them to the United States and Europe, the first Indian company to do 
so.At the end of her first year, Kiran Mazumdar Shaw used her earnings to buy a 
20-acre property, dreaming of future expansion.</span></p>
<h3 class="auto-style1" style="background: none rgb(255, 255, 255); font-weight: bold; margin: 0.3em 0px 0px; overflow: hidden; padding-top: 0.5em; padding-bottom: 0px; font-size: 1.2em; line-height: 1.6; font-family: sans-serif; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; border-bottom-style: none; border-bottom-color: inherit; border-bottom-width: medium;">
<span id="Expanding_into_biopharmaceuticals" class="mw-headline">Expanding into 
biopharmaceuticals</span></h3>
<p class="auto-style1" style="margin: 0.5em 0px; line-height: inherit; font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
Mazumdar-Shaw spearheaded Biocon's evolution from an industrial enzymes 
manufacturing company to a fully integrated bio-pharmaceutical company with a 
well-balanced business portfolio of products and a research focus on diabetes, 
oncology and auto-immune diseases.<span class="Apple-converted-space">&nbsp;</span>She 
also established two subsidiaries: Syngene (1994) which provides early research 
and development support services on a contract basis and Clinigene (2000) which 
focuses on clinical research trials and the development of both generic and new 
medicines.Clinigene was later merged with Syngene. Syngene was listed on BSE/NSE 
in 2015 and has a current market cap of US$1.15 billion.</p>
<p style="margin: 0.5em 0px; line-height: inherit; color: rgb(37, 37, 37); font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
<span class="auto-style1">Mazumdar-Shaw is responsible for establishing Biocon's 
direction. As early as 1984, she began to develop a research and development 
team at Biocon, focusing on discovery of novel enzymes and on development of 
novel techniques for solid substrate fermentation technology.The company's first 
major expansion came in 1987, when<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Narayanan_Vaghul" style="text-decoration: none; background: none;" title="Narayanan Vaghul">Narayanan 
Vaghul</a><span class="auto-style1">&nbsp;of<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/ICICI_Bank" style="text-decoration: none; background: none;" title="ICICI Bank">ICICI 
Ventures</a><span class="auto-style1">&nbsp;(Industrial Credit and Investment 
Corporation of India) supported creation of a venture capital fund of 
US$250,000The money enabled Biocon to expand its research and development 
efforts. They built a new plant featuring proprietary solid substrate 
fermentation technology based on a semi-automated tray culture process, inspired 
by Japanese techniques.<span class="Apple-converted-space">&nbsp;</span>In 1989, 
Biocon became the first Indian biotech company to receive US funding for 
proprietary technologies.</span></p>
<p style="margin: 0.5em 0px; line-height: inherit; color: rgb(37, 37, 37); font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
<span class="auto-style1">In 1990, Kiran Mazumdar incorporated Biocon 
Biopharmaceuticals Private Limited (BBLP) to manufacture and market a select 
range of biotherapeutics in a joint venture with the Cuban<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Center_of_Molecular_Immunology" style="text-decoration: none; background: none;" title="Center of Molecular Immunology">Center 
of Molecular Immunology</a><span class="auto-style1">.</span></p>
<h3 class="auto-style1" style="background: none rgb(255, 255, 255); font-weight: bold; margin: 0.3em 0px 0px; overflow: hidden; padding-top: 0.5em; padding-bottom: 0px; font-size: 1.2em; line-height: 1.6; font-family: sans-serif; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; border-bottom-style: none; border-bottom-color: inherit; border-bottom-width: medium;">
<span id="Establishing_independence" class="mw-headline">Establishing 
independence</span></h3>
<p style="margin: 0.5em 0px; line-height: inherit; color: rgb(37, 37, 37); font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
<span class="auto-style1">Biocon Biochemicals of Ireland was acquired from 
Leslie Auchincloss by<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Unilever" style="text-decoration: none; background: none;" title="Unilever">Unilever</a><span class="auto-style1">&nbsp;in 
1989.The partnership with Unilever helped Biocon to establish global best 
practices and quality systems.In 1997, Unilever sold its specialty chemicals 
division, including Biocon, to<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Imperial_Chemical_Industries" style="text-decoration: none; background: none;" title="Imperial Chemical Industries">Imperial 
Chemical Industries</a><span class="auto-style1">&nbsp;(ICI)<span class="Apple-converted-space">&nbsp;</span>In 
1998, Kiran Mazumdar's fiancée, Scotsman John Shaw, personally raised $2 million 
to purchase the outstanding Biocon shares from ICI<span class="Apple-converted-space">&nbsp;</span>The 
couple married in 1998, whereupon she became known as Kiran Mazumdar-Shaw. John 
Shaw left his position as chairman at Madura Coats to join Biocon.<span class="Apple-converted-space">&nbsp;</span>He 
became Biocon’s vice chairman in 2001.</span></p>
<p style="margin: 0.5em 0px; line-height: inherit; color: rgb(37, 37, 37); font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
<span class="auto-style1">In 2004, after seeking the advice of<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/N._R._Narayana_Murthy" style="text-decoration: none; background: none;" title="N. R. Narayana Murthy">Narayana 
Murthy</a><span class="auto-style1">, Kiran Mazumdar-Shaw decided to list Biocon 
on the stock market.Her intent was to raise capital to further develop Biocon's 
research programs. Biocon was the first biotechnology company in India to issue 
an IPO.<span class="Apple-converted-space">&nbsp;</span>Biocon's IPO was 
oversubscribed 33 times and its first day at the bourses closed with a market 
value of $1.11 billion,<span class="Apple-converted-space">&nbsp;</span>making Biocon 
only the second Indian company to cross the $1-billion mark on the first day of 
listing.</span></p>
<h3 class="auto-style1" style="background: none rgb(255, 255, 255); font-weight: bold; margin: 0.3em 0px 0px; overflow: hidden; padding-top: 0.5em; padding-bottom: 0px; font-size: 1.2em; line-height: 1.6; font-family: sans-serif; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; border-bottom-style: none; border-bottom-color: inherit; border-bottom-width: medium;">
<span id="Affordable_innovation" class="mw-headline">Affordable innovation</span></h3>
<p class="auto-style1" style="margin: 0.5em 0px; line-height: inherit; font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
Mazumdar-Shaw's belief in "affordable innovation" has been a driving philosophy 
behind Biocon's expansion. Inspired by the need for affordable drugs in 
less-wealthy countries, she has looked for opportunities to develop 
cost-effective techniques and lower-cost alternatives.<span class="Apple-converted-space">&nbsp;</span>She 
has also proposed that drug companies be cost-sensitive in marketing to 
developing countries, so that people can afford the drugs they need, 
particularly chronic therapies.</p>
<p style="margin: 0.5em 0px; line-height: inherit; color: rgb(37, 37, 37); font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
<span class="auto-style1">Mazumdar-Shaw noticed the market potential for<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Statins" style="text-decoration: none; background: none;" title="Statins">statins</a><span class="auto-style1">&nbsp;(cholesterol 
fighting drugs) early on. When the patent of the cholesterol-lowering drug<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Lovastatin" style="text-decoration: none; background: none;" title="Lovastatin">lovastatin</a><span class="auto-style1">&nbsp;expired 
in 2001, Biocon got involved in its development. Then they expanded to other 
forms of statins. Part of her strategy was to enter into long-term supply 
contracts, establishing a dependable market base over time. Statins soon 
accounted for over 50 per cent of the company's revenue.The company’s revenue 
went up from Rs. 70 crore in 1998, to Rs. 500 crore in 2004 when it went public.</span></p>
<p style="margin: 0.5em 0px; line-height: inherit; color: rgb(37, 37, 37); font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
<span class="auto-style1">Biocon continues to expand into new areas.<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Yeast_expression_platforms" style="text-decoration: none; background: none;" title="Yeast expression platforms">Yeast 
expression platforms</a><span class="auto-style1">&nbsp;offer a desirable alternative 
to mammalian<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Cell_cultures" style="text-decoration: none; background: none;" title="Cell cultures">cell 
cultures</a><span class="auto-style1">&nbsp;for the genetic manipulation of cells for 
use in a variety of drug treatments. Unicellular methylotrophic yeasts such as<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Pichia_pastoris" style="text-decoration: none; background: none;" title="Pichia pastoris">Pichia 
pastoris</a><span class="auto-style1">&nbsp;are used in the production of<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Vaccines" style="text-decoration: none; background: none;" title="Vaccines">vaccines</a>,<span class="auto-style1">&nbsp;</span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Antibody_fragment" style="text-decoration: none; background: none;" title="Antibody fragment">antibody 
fragments</a>,<span class="auto-style1">&nbsp;</span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Hormones" style="text-decoration: none; background: none;" title="Hormones">hormones</a>,<span class="auto-style1">&nbsp;</span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Cytokines" style="text-decoration: none; background: none;" title="Cytokines">cytokines</a><span class="auto-style1">, 
matrix proteins, and<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Biosimilar" style="text-decoration: none; background: none;" title="Biosimilar">biosimilars</a><span class="auto-style1">.</span></p>
<p style="margin: 0.5em 0px; line-height: inherit; color: rgb(37, 37, 37); font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
<span class="auto-style1">Biocon's major areas of research now include<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Cancer" style="text-decoration: none; background: none;" title="Cancer">cancer</a>,<span class="auto-style1">&nbsp;</span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Diabetes" style="text-decoration: none; background: none;" title="Diabetes">diabetes</a><span class="auto-style1">, 
and other<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Autoimmune_disease" style="text-decoration: none; background: none;" title="Autoimmune disease">auto-immune 
diseases</a><span class="auto-style1">&nbsp;such as<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Rheumatoid_arthritis" style="text-decoration: none; background: none;" title="Rheumatoid arthritis">rheumatoid 
arthritis</a><span class="auto-style1">&nbsp;and<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Psoriasis" style="text-decoration: none; background: none;" title="Psoriasis">psoriasis</a>.<span class="auto-style1">&nbsp;Because 
of the high percentage of people in India who chew betel or tobacco, India 
accounts for eighty-six per cent of oral cancer in the world, known locally as 
"cancer cheek".<span class="Apple-converted-space">&nbsp;</span>Diabetes is 
prevalent, and people who do not wear shoes are at risk to have a minor scrape 
or injury develop into<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Gangrene" style="text-decoration: none; background: none;" title="Gangrene">gangrene</a><span class="auto-style1">, 
or "diabetes foot".<span class="Apple-converted-space">&nbsp;</span>Biocon is also 
working on drugs to treat<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Psoriasis" style="text-decoration: none; background: none;" title="Psoriasis">psoriasis</a><span class="auto-style1">, 
a skin pigment disease which can result in social ostracization.</span></p>
<p style="margin: 0.5em 0px; line-height: inherit; color: rgb(37, 37, 37); font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
<span class="auto-style1">Bio-pharmaceuticals developed include Pichia-derived 
recombinant human<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Insulin" style="text-decoration: none; background: none;" title="Insulin">insulin</a><span class="auto-style1">&nbsp;and 
insulin analogs for diabetes, an Anti-EGFR<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Monoclonal_antibody" style="text-decoration: none; background: none;" title="Monoclonal antibody">monoclonal 
antibody</a><span class="auto-style1">&nbsp;for head and neck cancer, and a<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Biologic_medical_product" style="text-decoration: none; background: none;" title="Biologic medical product">biologic</a><span class="auto-style1">&nbsp;for 
psoriasis.<span class="Apple-converted-space">&nbsp;</span>Biocon is Asia's largest 
insulin producer,<span class="Apple-converted-space">&nbsp;</span>and has the largest 
perfusion-based antibody production facilities.</span></p>
<p class="auto-style1" style="margin: 0.5em 0px; line-height: inherit; font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
As of 2014, Biocon directed about 10% of its revenue back into research and 
development, a much higher proportion than most Indian pharmacological 
companies.<span class="Apple-converted-space">&nbsp;</span>Biocon has filed at least 
950 patent applications as a result of its research activity.Mazumdar-Shaw has 
actively engaged in acquisitions, partnerships and in-licensing within the 
pharmaceuticals and bio-pharmaceutical area, entering into more than 2,200 
high-value R&amp;D licensing and other deals between 2005 and 2010.</p>
<h2 class="auto-style1" style="background: none rgb(255, 255, 255); font-weight: normal; margin: 1em 0px 0.25em; overflow: hidden; padding: 0px; border-bottom: 1px solid rgb(170, 170, 170); font-size: 1.5em; font-family: &quot;Linux Libertine&quot;, Georgia, Times, serif; line-height: 1.3; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px;">
<span id="Philanthropic_activities" class="mw-headline">Philanthropic activities</span></h2>
<p style="margin: 0.5em 0px; line-height: inherit; color: rgb(37, 37, 37); font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
<span class="auto-style1">In 2004, Kiran Mazumdar-Shaw started a corporate 
social responsibility wing at Biocon, the Biocon Foundation. The Foundation 
focuses on the areas of health, education and infrastructure, especially in 
rural areas of<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Karnataka" style="text-decoration: none; background: none;" title="Karnataka">Karnataka</a><span class="auto-style1">&nbsp;which 
lack healthcare facilities.</span></p>
<p style="margin: 0.5em 0px; line-height: inherit; color: rgb(37, 37, 37); font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
<span class="auto-style1">Mazumdar-Shaw dislikes the term "philanthropy", 
believing that it often provides temporary fixes rather than changing underlying 
conditions.She prefers the term "compassionate capitalist", believing that 
properly applied business models can provide an ongoing foundation for 
sustainable social progress. "Innovation and commerce are as powerful tools for 
creating social progress as they are for driving technological advancement... 
when they are put to use for social progress, the implementation is a lot 
cheaper, a lot more people benefit, and the effect is more lasting."In 2015, she 
joined<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/The_Giving_Pledge" style="text-decoration: none; background: none;" title="The Giving Pledge">The 
Giving Pledge</a><span class="auto-style1">, promising that at least half of her 
wealth will be dedicated to philanthropy.</span></p>
<h3 class="auto-style1" style="background: none rgb(255, 255, 255); font-weight: bold; margin: 0.3em 0px 0px; overflow: hidden; padding-top: 0.5em; padding-bottom: 0px; font-size: 1.2em; line-height: 1.6; font-family: sans-serif; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; border-bottom-style: none; border-bottom-color: inherit; border-bottom-width: medium;">
<span id="Health" class="mw-headline">Health</span></h3>
<p class="auto-style1" style="margin: 0.5em 0px; line-height: inherit; font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
India does not have organized healthcare programs such as socialised medicine or 
government-backed health insurance.Rural areas may have only one doctor for 
every two thousand people: it is estimated that 70 million people do not have 
the money to pay for a doctor's visit or for medicine.<span class="Apple-converted-space">&nbsp;</span>The 
Biocon Foundation is involved in numerous health and education outreach programs 
to benefit the economically weaker sections of Indian society.</p>
<h4 class="auto-style1" style="background: none rgb(255, 255, 255); font-weight: bold; margin: 0.3em 0px 0px; overflow: hidden; padding-top: 0.5em; padding-bottom: 0px; font-size: 14px; line-height: 1.6; font-family: sans-serif; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; border-bottom-style: none; border-bottom-color: inherit; border-bottom-width: medium;">
<span id="Arogya_Raksha_Yojana" class="mw-headline">Arogya Raksha Yojana</span></h4>
<p style="margin: 0.5em 0px; line-height: inherit; color: rgb(37, 37, 37); font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
<span class="auto-style1">With Dr.<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/wiki/Devi_Shetty" style="text-decoration: none; background: none;" title="Devi Shetty">Devi 
Shetty</a><span class="auto-style1">&nbsp;of Narayana Hrudayalaya Hospital, 
Mazumdar-Shaw has supported the development of<span class="Apple-converted-space">&nbsp;</span></span><a class="auto-style1" href="https://en.wikipedia.org/w/index.php?title=Arogya_Raksha_Yojana&amp;action=edit&amp;redlink=1" style="text-decoration: none; background: none;" title="Arogya Raksha Yojana (page does not exist)">Arogya 
Raksha Yojana</a><span class="auto-style1">&nbsp;(Disease Protection Program/Health 
Help).Through this program Biocon Foundation establishes clinics to offer 
clinical care, generic medicines and basic tests for those who cannot afford 
them.<span class="Apple-converted-space">&nbsp;</span>As of 2010, seven clinics each 
served a population of 50,000 patients living within a radius of 10&nbsp;km, treating 
in total more than 300,000 people per year.Clinics organize regular general 
health checks in remote villages by bringing in physicians and doctors from 
network hospitals. To improve early detection of cancer, they have trained young 
women as community health workers, using smart phones to send photographs of 
suspicious lesions to oncologists at the cancer center.<span class="Apple-converted-space">&nbsp;</span>Public 
health campaigns such as "Queen of Heart" educate people about specific health 
issues and promote early detection of problems such as cardiovascular disease.</span></p>
<p style="margin: 0.5em 0px; line-height: inherit; color: rgb(37, 37, 37); font-family: sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: normal; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255);">
<span class="auto-style1">The clinics operate on a model of micro-financed 
health insurance.Biocon provides low-cost drugs, making a negligible profit on a 
unit basis, but an overall profit on volume due to the participation of large 
numbers of people.Clinics also use a "subsidised convenience" pricing plan, 
under which more wealthy patrons pay full price in return for the convenience of 
scheduling their visits and procedures at desirable times, while poorer patients 
can obtain cheap or even free services by choosing less desirable times.</span><sup id="cite_ref-BABL2013_43-3" class="reference" style="line-height: 1; unicode-bidi: isolate; white-space: nowrap; font-size: 11.2px; font-weight: normal; font-style: normal;"><a class="auto-style1" href="https://en.wikipedia.org/wiki/Kiran_Mazumdar-Shaw#cite_note-BABL2013-43" style="text-decoration: none; background: none; white-space: nowrap;">[43]</a></sup><span class="auto-style1">Doctors 
and researchers look for opportunities to use cutting-edge technology in ways 
that will drive down costs and ensure quality of service.</span></p>

</body>

</html>
